24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
Dr. Christos Colovos is a recognized general surgeon in Los Angeles, California. He received his medical diploma from the University of Pittsburgh School of Medicine. After getting his medical degree, he did an internship in general surgery at Cedars-Sinai Medical Center. Dr. Colovos completed his medical education with two residencies in general surgery, and a fellowship in surgical critical care, all of them at Cedars-Sinai Medical Center and a post doctoral fellowship at the Memorial Sloan-Kettering. He is certified by the American Board of Surgery as a physician, his license being active in California through 2017. His subspecialties are: general surgery, trauma surgery & surgical critical care. This doctor works at Cedars-Sinai Medical Center and at the Department of Surgery in West Hollywood. He has published many articles in cooperation with other doctors. He is a member of the medical organizations: Society of Thoracic Surgeons, American Association for Thoracic Surgery and American College of Surgeons. Besides English, he can speak French and Greek. He has practiced medicine between 6 and 10 years.
University of Pittsburgh
Medical School
Cedars-Sinai Medical Center
Internship
Cedars-Sinai Medical Center
Residency
American Board of Surgery
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
Adusumilli, P. S.,Cherkassky, L.,Villena-Vargas, J.,Colovos, C.,Servais, E.,Plotkin, J.,Jones, D. R.,Sadelain, M.; Sci Transl Med. 2014 Nov 08.
See more >>FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Kadota, K.,Colovos, C.,Suzuki, K.,Rizk, N. P.,Dunphy, M. P.,Zabor, E. C.,Sima, C. S.,Yoshizawa, A.,Travis, W. D.,Rusch, V. W.,Adusumilli, P. S.; Ann. Surg. Oncol.. 2012 Oct.
See more >>Safety and stability of retrovirally transduced chimeric antigen receptor T cells.
Colovos, C.,Villena-Vargas, J.,Adusumilli, P. S.; Immunotherapy. 2012 Oct 11.
See more >>